| S. No. |
Product Name |
|
| |
|
|
| 1) |
Montelukast Sodium API (Infringing) |
Technical Package Available |
|
| 2) |
Montelukast Sodium API (Non Infringing) |
Technical Package Available |
|
| 3) |
Montelukast intermediates |
|
| |
|
|
| |
| Code |
Chemical Name |
CAS No. |
| |
|
|
| ML5 |
{3-[(E)-2(7-chloro-quinolin-2-yl)-vinyl]-phenyl}- 3-[2-(1-hydroxy-1-methyl-ethyl)-phenyl]- propan-1-ol |
142569-70-8 |
| |
|
|
| ML3 |
2-(3-{3-[2-(7-Chloro-quinolin-3-yl)-vinyl]-phenyl}-3-oxo-propyl)-benzoic acid methyl ester |
181139-72-0 |
| |
|
|
| ML4 |
Methyl-2-3-(S)-(3-(2-7-chloro-2-quinolinyl)-ethenyl)phenyl)-3-hydroxypropyl)benzoate |
181139-72-0 |
| |
|
|
| MS4 |
[1-(mercaptomethyl)cyclopropyl]acetic acid |
162515-68-6 |
| |
|
|
| ML13 |
(R)-(E)-1-[[[-1-[3-[2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1 -hydroxy1methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic acid |
158966-92-8 (Montelukast acid) |
| |
|
|
| MS2 |
2-[1-( Hydroxymethyl)-cyclopropyl]-acetonitrile |
--- |
| |
|
|
|
|
| 4) |
Grignard Reagents : |
|
|
| |
Vinyl Magnesium Bromide
Vinyl Magnesium Chloride
Methyl Magnesium Bromide
Methyl Magnesium Chloride
Ethyl Magnesium Chloride
Ethyl Magnesium Bromide
Allyl Magnesium Chloride |
|
|
| 5) |
Phosgene Based Intermediates |
|
|
| 6) |
Di Ethyl Zinc |
CAS No. 557-20-0 |
|
| 7) |
Di Ethyl Methoxy Borane |
CAS No. 7397-46-8 |
|
| 8) |
Di Iso Butyl Aluminium Hydride |
CAS No. 1191-15-7 |
|
| 9) |
Tri Ethyl Borane |
CAS No. 97-94-9 |
|
| 10) |
(-)Diisopinocampheylchloroborane |
|
|
| 11) |
Irbesartan |
|
|
| 12) |
Irbesartan & Intermediates |
|
|
| |
1-[(2`-cyanobiphenyl-4-yl)methyl]-2-n-butyl]-4-spirocyclo pentane -2-imidazolin-5-one |
|
|
| |
2-n-butyl-4-spirocyclopentane-1-[[2’-(triphenyl methyl tetrazol-5-yl)biphenyl-4-yl]methyl]-2-imidazolin-5-one |
|
|
| 13) |
Candesartan |
|
|
| 14) |
Candesartan Intermediates |
|
|
| |
Ethyl1-[(2'-cyanobiphenyl-4-yl)methyl]-2-ethoxyben-zimidazole-7-carboxylate |
|
|
| |
Ethyl2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl]benzimidazole-7-carboxylate |
|
|
| |
2-Ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl-benzimidazole-7-carboxylic acid |
|
|
| |
2-Ethoxy-1-[[2'-(N-triphenylmethyltetrazol-5-yl)-biphenyl-4-yl]methyl]benzimidazole-7-carboxylic acid |
|
|
| |
1-(Cyclohexyloxycarbonyloxy)ethyl2-ethxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-benzimidazole-7-carboxylate |
|
|
| 15) |
Valsartan |
|
|
| 16) |
Valsartan Intermediates |
|
|
| |
N-[(2`cyano biphenyl-4yl)methyl]-(L)-valine benzyl ester. HCl |
|
|
| |
N-Valeryl-N-[(2`cyano biphenyl-4yl) methyl]-(L)-valine benzyl ester |
|
|
| 17) |
Telmisartan |
|
|
| 18) |
Telmisartan Intermediates |
|
|
| |
2-butyrylamino-3-Amino-5-(1-methyl-benzimidazo-2-yl) toluene |
|
|
| |
2-propyl-4-methyl-6-(1-methyl-2-benzimidazolyl) benzimidazole |
|
|
| |
t-Butyl-4`-[[4-methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl]methyl]-2-biphenyl carboxylate |
|
|
| 19) |
Modafinil |
|
|
| 20) |
Effavirenz & Intermediates |
|
|
| |
4-chloroaniline |
|
|
| |
N-(4-chlorophenyl)-2,2-dimethyl propanamide |
|
|
| |
1-(2-amino-5-chlorophenyl)-2,2,2-trifluoroethanone |
|
|
| |
2-(2-amino-5-chlorophenyl)-4-cyclopropyl-1,1,1-trifluorobut-3-yn-2-ol |
|
|
| |
(4S)-6-chloro-4-(cyclopropyl ethynyl) -4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one (EFAVIRENZ) |
|
|
| 21) |
Topiramate & Intermediates |
|
|
| 22) |
Rupatadine Fumarate |
|
|
| 23) |
Biperiden Hydrochloride |
|
|
| 24) |
Duloxetine & intermediates |
|
|
| |
2-Acetyl thiophene |
|
|
| |
N-(4-chlorophenyl)-2,2-dimethyl propanamide |
|
|
| |
-[2-(dimethyl amino)ethyl]-2-thiophene methanol |
|
|
| |
N,N-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine |
|
|
| |
(+)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propanamine [DULOXETIN] |
|
|
| |
DULOXETIN OXALATE |
|
|
| 25) |
18-Crown-6 |
CAS No.17455-13-9 |
|
| 26) |
15-Crown-5 |
CAS No. 33100-27-5 |
|
| 27) |
Dibenzo-18-Crown-6 |
CAS No. 14187-32-7 |
|
| 28) |
Cisapride |
|
|
Cisapride Intermediates
|
|
| |
| |
|
| CP10 |
Cis-4-amino-3-methoxy peperidine-1-carboxylic acid ethyl ester mono HCl |
| |
|
| CP7 |
Cis-4-amino-5-chloro-n-(3-methoxy-4-piperidinyl)-2-methoxybenzamide |
| |
|
| Intermediates :- |
| |
| |
3-benzoyloxy-4-methoxy-6-bromo benzoic acid (Galanthamine) |
|
| |
1-0-carbobentyloxy-2,3-0-dicloroactyl-4,6-ethylidene-B-D-glukopyranose (Etoposide) |
|
| |
4-[(4-methyl-1-piperazinyl)methyl]-N-[methyl-3-[4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]benzamide methanesulfonate (Imantinib) |
|
| |
(R(-)-5-(2-Aminopropyl)-2-methoxy benzene sulphonamide (Tamsulosin) |
|
| |
(2R-Cis)-2-Hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane,HCL (Emtricitabine) |
|
| |
4-methyl-1-(pyridin-3-yl)pent-2-en-1-one (Imantinib) |
| |
|
|
